Medical specialists from France tagged as investigators in clinical trials studying Lymphoblastic Lymphoma
Total 73 results
-
Andre Baruchel, MDSeen in:
- Paris, University Hospital Robert Debre
Trials:- NCT04984356 (Principal Investigator)
-
Anne Jourdain, MDSeen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:- NCT05792007 (Sub-Investigator)
-
Anne Sirvent, MD PhDSeen in:
- Montpellier, Hopital Arnaud de Villeneuve
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Arnaud Petit, M.D.Seen in:
- Paris, CHU Paris Armand Trousseau
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Aurélie CABANNES-HAMYSeen in:
- Paris, CABANNES-HAMY Aurélie
Trials:- NCT03751072 (Principal Investigator)
-
Benedicte Bruno, MD PhDSeen in:
- Lille, CHRU Lille, Service d'Hématologie Pédiatrique
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Camille Leglise, M.D.Seen in:
- Amiens Cedex 1, CHU Amiens Groupe Hospitalier Sud
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Carine Halfon-Domenech, M.D.Seen in:
- Lyon Cedex 08, CHU de Lyon HCL - GH Est-Institut d'hématologie et d'oncologie pédiatrique IHOP
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Caroline Thomas, M.D.Seen in:
- Nantes Cedex 01, CHU Nantes-Hôpital enfant-adolescent
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Catherine Devoldere, M.D.Seen in:
- Amiens Cedex 1, CHU Amiens Groupe Hospitalier Sud
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Catherine Paillard, M.D.Seen in:
- Strasbourg Cedex, CHU Strasbourg -Hôpital de Hautepierre
- Strasbourg, CHU Strasbourg, Service d'hématologie et d'oncologie pédiatrique
Trials:- NCT04307576 (Principal Investigator)
- NCT01949129 (Principal Investigator)
-
Cécile Pochon, M.D.Seen in:
- Nancy, CHU Nancy - Hôpital d'Enfants
- Vandoeuvre-les-nancy cedex, CHU de Nancy - Hôpital de Brabois Enfant
Trials:- NCT04307576 (Principal Investigator)
- NCT01949129 (Principal Investigator)
-
Charlotte Jubert, MD PhDSeen in:
- Bordeaux, CHU Bordeaux
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Christophe Piguet, M.D.Seen in:
- Limoges, Hôpital de la mère et de l'enfant
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Claire Desplantes, M.D.Seen in:
- Dijon, CHU Dijon Hôpital François Mitterrand
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Claire Pluchart, M.D.Seen in:
- Reims, CHU Reims-American Hospital
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Corine Armari AllaSeen in:
- Grenoble Cedex 9, CHU de Grenoble site Nord - Hôpital Albert Michallon
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Damien Bodet, M.D.Seen in:
- Caen Cedex 9, Centre Hospitalier Universitaire Caen
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Dominique Plantaz, MD PhDSeen in:
- Grenoble, CHU Grenoble - Clinique Universitaire de Pédiatrie, Hôpital Couple Enfant
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Emmanuel Gyan, MD-PhDSeen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:- NCT05792007 (Sub-Investigator)
-
Fanny Rialland, MD PhDSeen in:
- Nantes, CHU Nantes, Service d'onco hémato pédiatrie
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Francoise HuguetSeen in:
- Angers, CRLCC Centre Paul Papin
- Midi-pyrenees, Toulouse Cedex 09, Institut Universitaire Du Cancer de Toulouse Oncopole
- Toulouse, University Hospital, Toulouse
Trials:- NCT03589326 (Principal Investigator)
- NCT00188084 (Sub-Investigator)
- NCT05963061 (Sub-Investigator)
-
Frédéric MillotSeen in:
- Poitiers Cedex 6, CHU Poitiers
- Poitiers, Chu Poitiers Chu La Miletrie
Trials:- NCT04307576 (Principal Investigator)
- NCT05180825 (Principal Investigator)
-
Gerard Michel, MD PhDSeen in:
- Marseille, Hopital la Timone Adulte
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Guillaume CARTRON, MD PHDSeen in:
- Montpellier, CHU Montpellier
- Montpellier, Département d'hématologie clinique
Trials:- NCT04703686 (Principal Investigator)
- NCT04290000 (Principal Investigator)
-
Jean-Hugues Dalle, MD PhDSeen in:
- Paris, Hopital Robert Debre
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Jill Serre, MDSeen in:
- Tours, Service d'onco-hématologie pédiatrique -CHRU Tours
Trials:- NCT05792007 (Sub-Investigator)
Clinical Trials on Lymphoblastic Lymphoma
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnRecurrent Adult Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic Lymphoma | B Lymphoblastic Lymphoma | Recurrent T Lymphoblastic Leukemia/Lymphoma | Refractory T Lymphoblastic Lymphoma | T Acute Lymphoblastic Leukemia | T...United States
-
Mehrdad Abedi, MDAmgenCompletedStage IV Adult Lymphoblastic Lymphoma | Contiguous Stage II Adult Lymphoblastic Lymphoma | Noncontiguous Stage II Adult Lymphoblastic Lymphoma | Stage I Adult Lymphoblastic Lymphoma | Stage III Adult Lymphoblastic Lymphoma | Untreated Adult Acute Lymphoblastic LeukemiaUnited States
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic...Netherlands
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
National Cancer Institute (NCI)Active, not recruitingAdult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditionsUnited States, Canada, Australia, New Zealand
-
Beam Therapeutics Inc.RecruitingLymphoblastic Lymphoma | Lymphoblastic Leukemia | T-Cell Lymphoblastic Leukemia/LymphomaUnited States
-
Children's Hospital Medical Center, CincinnatiTerminatedRecurrent Adult Lymphoblastic Lymphoma | Refractory Acute Lymphoblastic Leukemia | Refractory Lymphoblastic Lymphoma | Relapsed Lymphoblastic LeukemiaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); The Leukemia...TerminatedT-Acute Lymphoblastic Leukemia | Adult T Lymphoblastic LymphomaUnited States